The growth of cell and gene therapies in the last decade has been both quick and vast.  From small start-ups to large pharmaceutical companies, many are looking to join the fray and bring the next critical therapy to market.

This session will open a discussion around the challenges around specifying, installing and qualifying/validating multiple systems with software with varying degrees of capability to produce a robust system for manufacturing, testing and releasing cell and gene products.

Add Aaron's session to your INTERPHEX 2021 plan!